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Abstract 
Objective: Patients with medically unexplained syndromes (MUS) often do not receive appropriate 
healthcare. A critical time for effective healthcare is the inception of MUS. The current study examined 
data from a prospective longitudinal study of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/
OIF) soldiers to understand the relationship of increasing physical symptom burden to healthcare 
utilization. 
Methods: Data was examined from a prospective study of OEF/OIF soldiers assessed before and one 
year after deployment (n = 336). Physical symptom burden was measured with the Patient Health 
Questionnaire (PHQ-15). Analyses were conducted with polynomial regression and response surface 
analysis (RSA). 
Results: Increases in physical symptom burden predicted greater healthcare utilization one year after 
deployment: primary care practitioner (slope = − 0.26, F = 4.07, p = 0.04), specialist (slope = − 0.43, F = 
8.67, p = 0.003), allied health therapy (e.g., physical therapy) (slope = − 0.41, F = 5.71, p = 0.02) and mental 
health (slope = − 0.32, F = 4.04, p = 0.05). There were no significant difference in utilization between those 
with consistently high levels and those with increases in physical symptom burden. 
Conclusion: This is the first prospective study to examine, and show, a relationship between onset of 
clinically significant physical symptoms and greater healthcare utilization. Our data suggest that patients 
with increasing physical symptom burden have the same level of healthcare as patients with chronic 
physical symptom burden. Needed next steps are to better understand the quality of care at inception and 
determine how to intervene so that recommended approaches to care are provided from the onset. 
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A B S T R A C T
Objective: Patients with medically unexplained syndromes (MUS) often do not receive appropriate healthcare. A
critical time for effective healthcare is the inception of MUS. The current study examined data from a prospective
longitudinal study of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) soldiers to understand
the relationship of increasing physical symptom burden to healthcare utilization.
Methods: Data was examined from a prospective study of OEF/OIF soldiers assessed before and one year after
deployment (n= 336). Physical symptom burden was measured with the Patient Health Questionnaire (PHQ-
15). Analyses were conducted with polynomial regression and response surface analysis (RSA).
Results: Increases in physical symptom burden predicted greater healthcare utilization one year after deploy-
ment: primary care practitioner (slope =−0.26, F = 4.07, p = 0.04), specialist (slope =−0.43, F = 8.67,
p = 0.003), allied health therapy (e.g., physical therapy) (slope =−0.41, F = 5.71, p= 0.02) and mental
health (slope =−0.32, F = 4.04, p= 0.05). There were no significant difference in utilization between those
with consistently high levels and those with increases in physical symptom burden.
Conclusion: This is the first prospective study to examine, and show, a relationship between onset of clinically
significant physical symptoms and greater healthcare utilization. Our data suggest that patients with increasing
physical symptom burden have the same level of healthcare as patients with chronic physical symptom burden.
Needed next steps are to better understand the quality of care at inception and determine how to intervene so
that recommended approaches to care are provided from the onset.
1. Introduction
An estimated 20% of primary care patients present with medically
unexplained syndromes or chronic symptom disorders (e.g., fibromyal-
gia, chronic fatigue syndrome) [1–5]. We use the term MUS as umbrella
term to refer to conditions defined by multiple chronic physical
symptoms not better defined by another disorder; for a discussion of
terminology around MUS see [2,6–9]. Despite the name, MUS can be
partially explained by a complex interaction of physiological and
psychological factors [4]. MUS causes disability that is as severe, or
worse than, the disability of medically known conditions (e.g., cancer
[10,11]).
Further exacerbating the burden of MUS, patients with MUS often
do not receive appropriate healthcare. They have up to double the
annual healthcare costs and utilization as compared to patients without
MUS [12]. This healthcare is typically focused on trying to identify the
cause of the symptoms [13–17] leading to extensive diagnostic testing,
hospitalizations, inappropriate prescription of opioids [12–19] and care
that is not patient-centered [20,21]. In contrast, recommended ap-
proaches to care for patients with MUS focus on patient-centered
management of symptoms including: [1] a primary care provider
evaluating the symptoms; [2] regular visits with the primary care
provider to reduce emergency and unnecessary care; and [3] use of
non-pharmaceutical, evidence-based treatments such as cognitive be-
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havioral therapy as a first line approach to care [22–30].
Considering the vicious cycle of symptom occurrence, inactivity,
deconditioning, and then worsening of symptoms and disability, a
critical time for effective healthcare is at the inception of MUS [31,32].
Despite this, no study has followed patients at the development of MUS
to understand when healthcare utilization increases and what types of
healthcare are received at the onset. One reason for this knowledge gap
is that it is difficult to identify who will develop MUS [32]. Combat
exposure is, however, a known risk factor for developing MUS and an
estimated 30% of combat veterans will develop chronic MUS [33–35].
We used data from an existing study which assessed combat veterans
prospectively from before to after deployment to help us understand the
frequency and type of health care utilization that occurs early in the
development of MUS.
While no study has prospectively looked at the relationship between
onset of MUS and healthcare utilization, there are reasons to hypothe-
size that healthcare utilization increases immediately. Cross-sectional
evidence finds a linear relationship between greater physical symptom
burden and increased healthcare utilization [12]. Studies of the
development of MUS recruit patients using healthcare, suggesting that
patients are seeking healthcare at the onset [14,36,37]. Thus, our
primary hypothesis is that there will be an association between increases
in physical symptom burden (from before to one year after deployment) and
greater healthcare utilization one year after deployment.
Increases in healthcare utilization may continue to increase over the
duration of MUS. Two prospective studies of patients with long-
standing MUS found healthcare utilization increased over time
[38,39]. Further, a cross-sectional study of unexplained symptoms near
the onset of symptoms, found a relationship between greater duration
and increased healthcare utilization [40]. Thus, our second hypothesis is
that healthcare utilization increases with duration of MUS. Specifically,
soldiers who report consistently high physical symptom burden (before and
after deployment) will report more healthcare utilization one year after
deployment as compared to veterans who reported an increase in physical
symptom burden (new onset MUS).
To test these hypotheses, we used data from a prospective study of
Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF)
soldiers assessed before and one year after deployment. Physical
symptom burden was measured with the Patient Health
Questionnaire (PHQ-15), which has been used to screen for clinically
significant levels of MUS [35]. Analyses were conducted with poly-
nomial regression and response surface analysis (RSA) which allowed
us to test the relationships in three dimensions and assess the influence




The HEROES project recruited Army National Guard and/or Reserve
soldiers prior to deployment to Operation Enduring Freedom/
Operation Iraqi Freedom (OEF/OIF) from 2005 to 2008. Soldiers were
approached during their standard preparation for deployment (for
description see [35,41–43]). Soldiers between 18 and 60 were invited
to participate. Based on their influence on physical symptoms, exclu-
sion criteria included (a) self-reported bipolar disorder, major depres-
sion, or schizophrenia, (b) high blood pressure, (c) certain medication,
or (d) pregnancy. At the start of the study, 795 participants were
eligible; 28 soldiers were excluded from analysis because they (a)
ultimately were not deployed, (b) were officers, or (c) were killed in
action.
2.2. Procedure
All study materials and procedures were reviewed by relevant
institutional review boards and research development committees.
Responses to questionnaires were collected across four phases: [1]
before deployment, [2] immediately upon return from deployment, [3]
three-months after deployment, and [4] one-year after deployment.
Before deployment and immediately after deployment, questionnaires
were administered in-person on base or through the mail. Question-
naires were administered and collected through the mail for the other
phases. The current data analysis was from the before deployment
(n = 767) and one year after deployment (n= 336) time points.
2.3. Measures
2.3.1. Patient Health Questionnaire-15
Participants completed the PHQ-15 which asks how burdened they
were by physical symptoms over the past fourteen days. Each item was
measured on a scale from 0 = not bothered at all to 2 = bothered a lot.
Burden was assessed using established threshold: above 15 was high, 10
to 14 was medium, 5 to 9 was low, and 0 to 4 was no/mild [44]. We
used the pre-determined physical symptom cut-offs as this allows
interpretation between clinically significant (MUS; medium and high)
and clinically non-significant (no-MUS; no/mild and low) levels of
physical symptom burden and reduced the influence of outliers in our
three dimensional graphs. The PHQ-15 is a screening instrument for
MUS; the measure does not distinguish between medically explained
and unexplained symptoms. The PHQ-15 had an internal consistency of
α= 0.75 before deployment and α= 0.69 one year after deployment
in our sample.
2.3.2. Healthcare utilization
Healthcare utilization questions were adapted from the National
Health Interview Survey [45,46]. Items asked about healthcare utiliza-
tion in the past year including primary care practitioner, specialty care,
allied health therapy (e.g., physical therapy, occupational therapy) and
mental health. Before deployment, soldiers were asked if they had seen
any specialist. At one year after deployment, they were asked how
many times they had seen a gastroenterologist, pulmonologist, rheu-
matologist, neurologist or other specialist; these items were added
together for a total specialist score. Before deployment, the utilization
questions asked if the soldier had received each type of care (yes/no)
and there was one question that asked how many medical appointments
they had in the past year. At one year after deployment, soldiers were
asked if they had received each type of care and how many times they
had received each type of care in the past year. To address the positive
skew of the count items, after data collection these were transformed
into a Likert scale consistent with the National Health Interview Survey
(0, 1, 2–3, 4–9, 10 and above visits).
2.4. Analysis
Paired t-tests and McNemar test were conducted to examine if
physical symptoms and healthcare utilization increased from before to
after deployment, a premise of our first hypothesis. A MANOVA was
used to determine the cross-sectional relationship between level of
physical symptom burden at one year after deployment and each of the
four types of healthcare utilization.
Hypothesis 1. There will be an association between increases in
physical symptom burden (from before to one year after deployment)
and greater healthcare utilization one year after deployment.
Polynomial regression and response surface analysis (RSA) [47–49]
were used to examine if changes in physical symptom burden were
related to healthcare utilization at one year after deployment. The
advantage of polynomial regression and RSA is that the relationships
are represented in three dimensions as can be seen in Fig. 1 [48–51].
This allows us to tell the influence of differing degrees and direction of
change in symptom burden on healthcare utilization, for different
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starting values of symptom burden. These nuances would not be
possible if one were to test a difference-score between before and after
deployment physical symptom burden as a single predictor or if one
were to create artificial groups of veterans based on their change in
symptom burden.
There are multiple steps to a polynomial regression analysis. In the
first step, a linear polynomial model is created with centered indepen-
dent variables (X = before deployment symptom burden and Y = after
deployment symptom burden) that predict the outcome (Z = after
deployment healthcare utilization). For the second step, a quadratic
model is created. This model includes X2, XY, and Y2. The third step a
cubic model is constructed, including X3, XY2, X2Y, Y3. When the cubic
model (third step) is significant, a quartic model (fourth step) is tested.
The interpreted step is the last step where the change in R2 is
statistically significant; for example, if the linear and quadratic step
are statistically significant and the cubic step is not, the quadratic step
is interpreted.
The polynomial and RSA analyses for this study controlled for
frequency of receiving any healthcare before deployment. The three
dimensional graph can only have three variables. To allow us to control
for healthcare utilization before deployment, we regressed the control
variable (healthcare utilization before deployment) on each dependent
variable and saved the unstandardized residual. We then conducted the
polynomial regression analysis using the each of these unstandardized
residuals as the dependent variables. The regression coefficients of the
final model were used to conduct the RSA analyses [48,49,51].
Fig. 1 shows the RSA. The Z-axis (vertical) is the dependent
variable, frequency of health care utilization, the X-axis is before
deployment symptom burden and the Y-axis is after deployment
symptom burden. A visual inspection of the graph shows the level of
healthcare utilization at different combinations of before and after
deployment symptom burden. To interpret the graph, it is useful to look
at the surface along the line of congruence, which is when X = Y or
when before symptoms are the same as after symptoms (solid perpen-
dicular line in Fig. 1a); and the surface along the line of incongruence,
which is when X + Y= 0 or before and after deployment symptoms are
different from each other (dashed perpendicular line in Fig. 1a). The
line of incongruence is conceptually the same as testing the difference
score (after minus before deployment symptom burden) as a predictor
of the outcome. Descriptions of polynomial regression and RSA can be
found in [48–51].
For Hypothesis 1, we were interested in the slope of the surface
along the line of incongruence. The slope of this line tells us: (a) if
healthcare utilization was greater when symptom burden increased, (b)
if healthcare utilization was greater when symptom burden decreased,
or (c) if there was no relationship between change in symptom burden
and healthcare utilization. We hypothesized a negative slope, which
would indicate that healthcare utilization was greater when symptom
burden increased from before to after deployment. We also examined if
there was curvature (if quadratic) of the surface along the line of
incongruence. This curvature would indicate that the relationship
between change in symptoms and healthcare utilization was not linear,
meaning that the association between change in symptoms and
healthcare utilization was different at the ends of the line of incon-
gruence as compared to the center of the line of incongruence.
We next examined the slope of the surface along the line of
congruence to understand if healthcare utilization was greater when
before and after symptom burden were both high as compared to when
both were low. Finally, we examined if there was curvature (if
quadratic) of the surface along the line of congruence which would
indicate that the relationship of consistently high or low symptom
burden and healthcare utilization was not linear, meaning that the
relationship between symptoms and healthcare utilization was different
when symptoms were consistently high as compared to constantly low.
Hypothesis 2. Soldiers who reported consistently high physical
symptom burden both before and after deployment would report
more healthcare utilization one year after deployment as compared to
veterans who reported an increase in physical symptom burden.
This was first determined by visual examination of the three
dimensional graph (See Fig. 1a–d). We next compared the healthcare
utilization of soldiers who had high levels of physical symptoms at
before and after deployment (high/high; defined as medium to high
physical symptom burden at both times) to soldiers who had low
physical symptoms at before and after deployment (low/low; defined as
no/mild to low physical symptom burden at both times) to soldiers who
reported low symptoms (defined as no/mild to low physical symptom
burden) at before deployment to high (defined as medium to high
physical symptom burden) one year after deployment (low/high). A
MANCOVA was conducted to determine if there were significant
differences between the groups in each of the four types of healthcare
utilization controlling for before deployment levels of healthcare
utilization. Unlike the polynomial regression, Soldiers were split into
groups (high/high, low/low, low/high) for a direct comparison of the
average levels of utilization between these groups. The ANCOVAs
report the effect size eta-squared which is the proportion of variance
for which the dependent variable accounted and Pillai's Trace which is
a test statistic.
3. Results
The majority of participants were male (n = 288, 86%), white
(n = 277, 82.4%) with a mean age of 30.2 (SD = 9.1). Participants
who completed the one-year assessment post-deployment (compared to
those who did not) were older and more likely to be male, and trend
towards reporting more healthcare utilization at baseline (1.1 vs. 0.9;
p = 0.07); there were no differences in physical symptom burden.
There was an average increase in physical symptom burden from
before to one year after deployment (Table 1; t= 8.13, p < 0.001).
There was also an average increase in healthcare utilization (Table 2;
All four of the McNemar test, p < 0.05).
Consistent with previous research, preliminary analysis using
MANOVA showed a cross-sectional relationship between greater phy-
sical symptom burden one year after deployment and greater health-
care utilization (primary care practitioner, specialist, therapy, mental
health care) one year after deployment (Table 3; Pillai's Trace = 0.23,
F912, 939) = 6.38, p < 0.001, Eta Squared = 0.08). The separate
univariate ANOVAs showed a cross-sectional relation between greater
level of physical symptom burden and more frequent visits to a primary
care (F(3,314) = 5.37, Eta Squared = 0.05), specialist (F(3,314)
= 17.61, Eta Squared = 0.14), allied health therapist (F(3,314)
= 11.16, Eta Squared = 0.10), and mental health services (F(3,314)
= 10.83, Eta Squared = 0.09).
Hypothesis 1. There will be an association between increases in
physical symptom burden (from before to one year after deployment)
and greater healthcare utilization one year after deployment.
3.1. Primary care practitioner
The linear model was the final model of the polynomial regression
analysis (R2 change = 0.05, p < 0.001; Fig. 1a, Table 4) which is
interpreted as follows. In support of the hypothesis, there was greater
utilization of a primary care practitioner when physical symptom
burden increased (from before to after deployment) as compared to
when physical symptom burden decreased; the slope of the surface
along the line of incongruence was significant and negative
(slope =−0.26, F = 4.07, p = 0.04). There was also greater utiliza-
tion of a primary care practitioner when physical symptoms burden was
consistently high as compared to when physical symptom burden was
consistently low; the slope of the surface along the line of congruence
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(when physical symptoms were equal at before and after deployment)
was positive and significantly greater than zero (slope = 0.25,
F = 7.97, p= 0.05).
3.2. Specialist care
The cubic model was the final model (R2 change = 0.05,
p < 0.001; Table 4) which is interpreted as follows. There was greater
utilization of a specialist when physical symptom burden increased
(from before to after deployment) compared to when physical symptom
burden decreased; the slope of the surface along the line of incon-
gruence was significant and negative (slope =−0.43, F = 8.67,
p = 0.003). Greater increases in physical symptom burden (towards
the end of the line of incongruence) were associated with much greater
utilization of specialist care; this is indicated by a significant curvature
of the surface along the line of incongruence (curvature = 0.71,
F = 13.86, p < 0.001). Similarly, when there were high levels of
physical symptom burden at both before and after deployment (line of
congruence) there was much greater utilization of specialist care; this is
indicated by a positive and significant curvature of the surface along
the line of congruence (curvature = 0.32, F = 10.14, p = 0.002). The
interpretation of the cubic component of the model is the same as
described above, except that, as indicated in the Fig. 1b, utilization was
lowest in the middle of the surface (for closer-to-average levels of
before and after symptom burden) than at the extremes.
3.3. Allied health therapy
The quadratic model was the final model of the polynomial
regression analysis for allied health therapy utilization (R2
Fig. 1. Three dimensional graphs of physical symptom burden before and one year after deployment predicting frequency of healthcare utilization.a
aThe line of congruence runs diagonally across each graph from the point of lowest symptom burden at both before and after deployment to the point of highest symptom burden at both
before and after deployment. This is depicted in Fig. 1a with a solid line. The line of incongruence runs perpendicular from the point of greatest discrepancy (when before physical
symptom burden are lowest and the after deployment symptom burden is highest) diagonally to the opposite corner. In 1a this is depicted with a dashed line. The slope of the line of
incongruence for each figure is significant demonstrating that increases in physical symptom burden are associated with greater healthcare utilization. Additional interpretations of the
slopes and curvature of the slopes are located in the results section.
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change = 0.02, p = 0.04; Fig. 1c, Table 4) which is interpreted as
follows. There was greater utilization of a therapist (e.g., physical
therapist) when physical symptom burden increased (from before to
after deployment) compared to when physical symptom burden de-
creased (see Fig. 1c); the slope of the surface along the line of
incongruence was significant and negative (slope = −0.41, F = 5.71,
p = 0.02). Greater increases in physical symptom burden were asso-
ciated with much greater allied health utilization as compared to lower
increases in physical symptom burden which were associated with
lower allied health utilization; this is indicated by significant curvature
of the surface along the line of incongruence (curvature = 0.52,
F = 5.40, p = 0.021). Finally, those with high levels of symptom
burden at before and after deployment used therapy significantly more
than those with low levels of symptom burden at before and after
deployment; the slope of the surface along the line of congruence (when
physical symptom burden before and after deployment were equal) was
positive and significantly greater than zero (slope = 0.26, F = 4.42,
p = 0.04).
3.4. Mental health
The polynomial regression analysis for mental health utilization
showed the linear model was the final model (R2 change = 0.10,
p < 0.001; Fig. 1d, Table 4), which is interpreted as follows. There
was greater utilization of mental health when physical symptom burden
increased (from before to after deployment) as compared to when
physical symptom burden decreased; the slope of the surface along the
line of incongruence was significant and negative (slope = −0.32,
F = 4.04, p= 0.05). Those with high level of symptom burden at
before and after deployment used mental health services significantly
more than those with low level of symptom burden at before and after
deployment; the slope of the surface along the line of congruence (when
physical symptom burden before and after deployment were equal) was
positive and significantly greater than zero (slope = 0.49, F= 20.86,
p < 0.001).
Hypothesis 2. Soldiers who report greater physical symptom burden
both before and after deployment, will report more healthcare
utilization one year after deployment compared to soldiers who
report an increase in physical symptom burden.
Visual inspection of the graphs of specialty care, allied health
therapy and mental health (Fig. 1a–d) suggest that for soldiers with
the highest levels of physical symptom burden, healthcare utilization
may be higher for those with consistently high levels of physical
symptom burden as compared to those who experience an increase in
physical symptom burden. This is consistent with hypothesis two.
We conducted a MANCOVA to further test this hypothesis, which
did not support hypothesis two (Table 5). As described below, while the
overall model was significant, there were no main effects differences in
healthcare utilization between soldiers who had an increase in physical
symptom burden as compared to soldiers with consistently high
physical symptom burden.
To conduct the MANCOVA, we split soldiers into three groups,
soldiers who had consistently high levels of physical symptom burden
(high/high) and soldiers who increased their physical symptom burden
(low/high) and soldiers who had consistently low levels of physical
symptom burden (low/low). The overall MANCOVA found the level of
physical symptom burden change (low/low, low/high, high/high) was
significantly related to healthcare utilization one year after deployment
(Table 5 Pillai's Trace = 0.10, F(8, 616) = 3.91, p < 0.001, Eta
Squared = 0.05). There was an association between physical symptom
burden change (low/low, low/high, high/high) and greater utilization
for primary care practitioner (F(2, 314) = 4.09, p = 0.02, Eta
Squared = 0.03), specialty physician (F(2, 314) = 6.62, p < 0.01,
Eta Squared = 0.04), allied health therapy (e.g., physical therapy; F
(2, 314) = 5.74, p < 0.01, Eta Squared = 0.04) and mental health
services (F(2, 314) = 10.49, p < 0.001, Eta Squared = 0.06).
Comparing the main effects, there were no significant differences
between soldiers with low/high or high/high levels of physical
symptoms burden, which was not supportive of hypothesis two.
Soldiers with low/low physical symptom burden had significantly less
healthcare utilization as compared to soldiers with low/high or high/
high levels of physical symptom burden.
4. Discussion
The onset of medically unexplained physical syndromes (MUS) is a
critical time for effective healthcare. Early intervention can lead to
management approaches that improve disability and symptoms in the
long-term. Despite this, no study has observed individuals from before
to after the development of physical symptoms to understand early
Table 1
Number of participants with each level of physical symptom burden (measured with the











































Deploy = deployment, Sx = symptoms, Yr = year.
Table 2
Number endorsing healthcare utilization before deployment and one year after deploy-
ment (n = 318).
Before deployment One year after deploymentb
Primary care 144 (44.0%) 217 (68.0%)
Specialista 33 (10.1%) 100 (31.1%)
Allied health 35 (10.6%) 82 (25.9%)
Mental health 28 (8.5%) 113 (35.4%)
a Before deployment soldiers were asked if they had seen any specialist. At 1 year after
deployment they were asked how many times they had seen a gastrologist, pulmonol-
ogist, rheumatologist, neurologist or other specialist, these items were added together for
a total specialist score.
b There was an average increase in healthcare utilization; a McNemar test for each type
of healthcare utilization was significant, p < 0.05.
Table 3
Cross-sectional relationship of Physical Symptom Burden to Healthcare Utilization one
year after deployment (% who self-reporting attending healthcare utilization; n= 318).
No/Mild Sx. Low Sx. Medium Sx. High Sx.
Primary care 60.7% 72.7% 73.3% 66.7%
Specialist 18.8% 35.4% 30.7% 63.6%
Allied health 10.8% 33.0% 29.3% 48.5%
Mental health 21.4% 36.4% 42.7% 63.6%
Sx. = symptoms.
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healthcare utilization. The current study examined data from a
prospective longitudinal study of Operation Enduring Freedom/
Operation Iraqi Freedom (OEF/OIF) soldiers to understand the relation-
ship of increasing physical symptom burden to healthcare utilization.
A premise of our hypotheses was that soldiers would have sig-
nificant increases in physical symptom burden from before to after
deployment; this was supported. Before deployment, 14% of soldiers
reported levels of physical symptoms burden that were likely clinically
significant. After deployment, this number rose to 33%. This increase is
consistent with previous studies which find approximately 30% of
combat veterans report clinically significant MUS [33,35,52]. This
study captured MUS with the PHQ-15 where ‘medium’ to ‘high’ levels
of MUS were considered clinically significant.
Increases in physical symptom burden predicted healthcare utiliza-
tion one year after deployment. This was true for all four types of
healthcare utilization: primary care, specialist, allied health therapy
(e.g., physical therapy) and mental health. To our knowledge, this is the
first study to show a relationship between onset of physical symptom
burden and greater utilization of multiple types of healthcare.
Importantly, all these analyses controlled for frequency of healthcare
utilization before deployment; controlling for baseline levels of utiliza-
tion controlled for the variance accounted for by the individual
tendency to seek healthcare. This suggests the results are not due to
some soldiers being simply more likely to seek healthcare.
Soldiers with high levels of physical symptom burden after deploy-
ment show patterns of utilization that is both consistent and incon-
sistent with current recommendations. With the Veterans Health
Administration's (VHA's) move to primary care homes, primary care
practitioners are more than ever expected to organize care in collabora-
tion with a team of healthcare professionals (e.g., psychologists,
physical therapists). In this setting, patients with MUS would ideally
receive more frequent care from their primary care, mental health and
allied health providers, who deliver treatments with the strongest
evidence (e.g., cognitive behavioral therapy). This study demonstrates
guideline congruent increases in primary, mental health, and allied
health care.
Clinical practice guidelines also suggest that specialist care be saved
for exclusionary testing or second opinions. In this study, however, the
slopes of incongruence (relationships between increasing physical
symptoms and healthcare utilization) were strongest for specialty care
and allied health therapy (0.43 and 0.42 respectively) and lower for
primary care practitioner and mental health care (0.25 and 0.32
respectively). The relationship between greater specialist care and
increases in physical symptom burden suggests that those with high
levels of physical symptom burden are receiving a significant portion of
their care from specialists, which is inconsistent with recommenda-
tions. Further, while it is encouraging that soldiers are using mental and
allied health care, they made, on average, one visit a year which is not
typically an effective dose of this care.
The hypothesis that soldiers with consistent high levels of physical
symptom burden would have greater utilization as compared to soldiers
who are first developing high levels of physical symptom burden was
not supported with the MANCOVA. Patients with MUS receive up to
double the levels of healthcare utilization and costs as compared to
patients with known medical conditions [12,18,19]. Our findings
suggest that inappropriate healthcare could be occurring from the start.
It is also possible that our comparison group of soldiers with consistent
levels of high physical symptoms is not representative of patients with
chronic MUS. Soldiers who had high levels of physical symptoms before
deployment may be healthier than civilians their age with MUS, as they
were healthy enough to deploy and their healthcare utilization was not
extremely high (Table 5). Alternatively, they may have been not
healthier than civilians with chronic MUS, but deployed out of an
obligation to their units.
While our MANCOVA results did not show significant difference
between those with consistently high levels of physical symptoms
(n = 83) and those with increases in physical symptom burden
(n = 29), the graphs suggest that there may be non-significant differ-
ences for soldiers with the most severe physical symptoms. As there
Table 4
Polynomial regression analyses of differing degrees of change in physical symptoms (from before to one year after deployment) predicting healthcare utilization one year after
deployment (n = 315).a
Primary care practitioner Specialist Mental health Allied health therapist
B (SE) ΔR2 B (SE) ΔR2 B (SE) ΔR2 B(SE) ΔR2
Step 1 Healthcare utilization (before) 0.14 (0.06)* 0.02* 0.09 (0.61) 0.01 0.06 (0.08) 0.00 0.11 (0.07) 0.01
Step 2 Healthcare utilization (before) 0.13 (0.06)* 0.05* 0.08 (0.06) 0.10* 0.03 (0.07) 0.10* 0.08 (0.07) 0.09*
PHQ-15 (before) −0.00 (0.09) −0.04 (0.09) 0.09 (0.11) 0.08 (0.10)
PHQ-15 (after) 0.26 (0.07)* 0.36 (0.06)* 0.41 (0.08)* 0.35 (0.08)*
Step 3 Healthcare utilization (before) 0.01 0.06 (0.06) 0.05* 0.02 0.07 (0.07) 0.02*
PHQ-15 (before) −0.16 (0.10) −0.07 (0.12)
PHQ-15 (after) 0.26 (0.07)* 0.33 (0.09)*
PHQ-15 (before)2 0.38 (0.11)* 0.38 (0.13)*
PHQ-15(before) *PHQ-15(after) −0.20 (0.09)* −0.18 (0.11)
PHQ-15 (after)2 0.14(0.07)* −0.02 (0.08)
Step 4^ 0.02 0.05* 0.01 0.02
a The regression coefficients are not directly interpretable but are used to calculate the lines of congruence (when symptoms are the same at baseline and one year after deployment)
and incongruence (when symptoms are different at baseline and one year after deployment). The slopes and curvatures of these calculated lines are in the results section, *p < 0.05,
B = unstandardized regression weight, SE = standard error, ΔR2 = change in R2 for each step - the change is incremental and the total R2 increases with each step, before = before
deployment, after = one year after deployment, PHQ-15 = physical symptom burden, ^Step 4 included step 1–3 variables, PHQ_15 (before)2 interaction with PHQ_15(after), PHQ_15
(after)2 interaction with PHQ_15 (after), PHQ_15 (before)3 and PHQ_15 (after)3. The beta weights of Step 4 are not directly interpretable and therefore not reported but are available upon
request.
Table 5
Relationship of level of physical symptom change (from before to one year after
deployment) to frequency* of healthcare utilization one year after deployment; mean*
(standard error) (n = 314).
Low/low Low/high High/high
Primary care practitioner 1.17 (0.08) 1.56 (0.13)a 1.52 (0.21)a
Specialist 0.49 (0.08) 0.88 (0.12)a 1.13 (0.21)a
Allied health therapy 0.50 (0.09) 0.99 (0.14)a 1.05 (0.24)a
Mental health 0.66 (0.10) 1.43 (0.15)a 1.36 (0.26)a
* = likert scale of number of visits in the past year where 0 = 0 visits, 1 = 1 visit and
2 = 2–3 visits, 3 = 4–9 visits, and 4 = 10 or more visits, Low/Low = no/mild to low
physical symptoms before deployment to no/mild to low physical symptoms one year
after deployment; Low/High = no/mild to low physical symptoms before deployment to
medium to high physical symptoms one year after deployment; High/High =Medium to
high physical symptoms before deployment to medium to high physical symptoms one
year after deployment. a = significant difference with low/low group.
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were only 13 soldiers with the highest levels of physical symptom
burden after deployment, we were not able to test this statistically.
Future research with a larger population is needed to test this
possibility.
A limitation of our study was not having a physician diagnosis of
MUS. The PHQ-15 is a common screening measure of MUS. The PHQ-15
does not differentiate between medically explained and unexplained
symptoms. This is consistent with current evidence that greater
symptom burden is impairing regardless of the cause [2,53] and has
led to calls to change the term from MUS to physical symptom disorder
or chronic multisymptom illness, among others [6,8,54]. As there is not
yet consensus on the best terminology, we used MUS to be consistent
with the current literature. Other terms [6,8,54], better reflect the
actual phenomena and what is captured by the PHQ-15, although are
less frequently used in the literature. Regardless of terminology,
physician diagnosis would help us understand if these symptoms were
clinically relevant.
This study also did not capture the quality of care. It is unknown if
soldiers were receiving appropriate treatments (e.g., cognitive-beha-
vioral therapy) or less appropriate treatments (e.g., opioids). It is also
unknown if soldiers receive patient-centered care at the onset of MUS.
Qualitative research finds some providers think treating MUS is
difficult, which can lead to frustration with the patient [55,56].
Another consideration is that the graphs for specialty and allied health
therapy were more complex (i.e., curvature) as compared to primary
care and mental health care (i.e., linear) which should be explored in
future studies.
The use of a military sample is a strength and limitation. Because
combat deployment is a risk factor for developing MUS, observing
soldiers before and after combat allowed us to prospectively observe
participants as they developed significant physical symptom burden.
Further, because MUS impacts 30% of combat veterans, this is an
important population for whom to improve the management of MUS.
We do not, however, know the generalizability of the results to a
civilian population and the changes to mailing addresses and telephone
numbers that occur from before to after deployment contributed to our
high attrition rate.
In summary, this is the first prospective study to examine, and show,
a relationship between onset of clinically significant physical symptoms
(MUS) and greater healthcare utilization. Our data also suggest that
patients with new onset physical symptom burden have the same levels
of healthcare utilization as patients with chronic physical symptom
burden. Effective healthcare can improve the management of MUS and
in the long-term reduce disability and physical symptoms. Next steps
are to better understand the quality of care at inception and determine
how to intervene so that recommended approaches to care are provided
from the start.
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